An open-label 12-month trial of mycophenolate mofetil in myasthenia gravis

被引：0
|
作者：
Gogovska, L. [1 ]
Ljapcev, R. [1 ]
机构：
[1] Dept Neuroimmunol, Neurol Clin, Skopje, Macedonia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial
    Putko, Brendan N.
    Beecher, Grayson
    Siddiqi, Zaeem A.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [42] Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial
    Strueber, M.
    Warnecke, G.
    Fuge, J.
    Simon, A. R.
    Zhang, R.
    Welte, T.
    Haverich, A.
    Gottlieb, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3171 - 3180
  • [43] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [44] Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity
    Lim, A. K. H.
    Donnan, G.
    Chambers, B.
    Ierino, F. L.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (01) : 55 - U7
  • [45] Do Clinical Characteristics Predict Response to Mycophenolate Mofetil in Myasthenia Gravis?
    Hobson-Webb, Lisa
    Juel, Vern
    Guptill, Jeff
    Massey, Janice
    Sanders, Donald
    NEUROLOGY, 2012, 78
  • [46] Mycophenolate mofetil as initial immunotherapy in generalised myasthenia gravis: a case report
    Gogovska, L
    Ljapcev, R
    JOURNAL OF NEUROLOGY, 2005, 252 : 133 - 133
  • [47] Mycophenolate mofetil as initial immunotherapy in generalized Myasthenia gravis: a case report
    Gogovska, L
    Ljapcev, R
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S173 - S174
  • [48] Mycophenolate Mofetil (MyM) is safe and well tolerated in Myasthenia Gravis (MG)
    Cos, L
    Mankodi, AK
    Tawil, R
    Thornton, CA
    NEUROLOGY, 2000, 54 (07) : A137 - A137
  • [49] Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
    Vernino, S
    Salomao, DR
    Habermann, TM
    O'Neill, BP
    NEUROLOGY, 2005, 65 (04) : 639 - 641
  • [50] Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Sato, Takeo
    Inokuma, Shigeko
    RHEUMATOLOGY, 2010, 49 (08) : 1607 - 1607
12345